Yan-Jing Zheng Selected Research

Inflammation (Inflammations)

8/2017

Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-κB/NLRP3 inflammasome activation and lipid metabolism disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan-Jing Zheng Research Topics

Disease

3	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 10/2021 - 08/2017
2	Glucose Intolerance 07/2018 - 09/2017
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2018 - 08/2017
1	Hypertrophy 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Encephalitis (Encephalitis, Rasmussen) 07/2018
1	Body Weight Changes 06/2018
1	Body Weight (Weight, Body) 06/2018
1	Type 2 Diabetes Mellitus (MODY) 09/2017
1	Anhedonia 09/2017
1	Inflammation (Inflammations) 08/2017
1	Liver Diseases (Liver Disease) 08/2017

Drug/Important Bio-Agent (IBA)

4	InflammasomesIBA 10/2021 - 08/2017
4	FructoseIBA 10/2021 - 08/2017
3	18alpha,20beta- hydroxy- 11- oxo- norolean- 12- en- 3beta- yl- 2- O- beta- D- glucopyranurosyl- alpha- D- glucopyranosiduronate magnesium tetrahydrateIBA 10/2021 - 08/2017
2	Insulin (Novolin)FDA Link 07/2018 - 09/2017
2	Antidepressive Agents (Antidepressants)IBA 07/2018 - 09/2017
1	pterostilbeneIBA 01/2019
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 07/2018
1	chaihu-shugan-sanIBA 07/2018
1	Sucrose (Saccharose)IBA 09/2017
1	SolutionsIBA 09/2017
1	Banxia Houpo TangIBA 09/2017
1	LipidsIBA 08/2017